Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a top… Read more
Journey Medical Corp (DERM) - Total Assets
Latest total assets as of September 2025: $85.19 Million USD
Based on the latest financial reports, Journey Medical Corp (DERM) holds total assets worth $85.19 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Journey Medical Corp - Total Assets Trend (2014–2024)
This chart illustrates how Journey Medical Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Journey Medical Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Journey Medical Corp's total assets of $85.19 Million consist of 60.0% current assets and 40.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.3% |
| Accounts Receivable | $10.23 Million | 12.8% |
| Inventory | $14.43 Million | 18.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $31.86 Million | 39.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Journey Medical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Journey Medical Corp's current assets represent 60.0% of total assets in 2024, an increase from 59.2% in 2014.
- Cash Position: Cash and equivalents constituted 25.3% of total assets in 2024, down from 31.1% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, an increase from 1.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 39.7% of total assets.
Journey Medical Corp Competitors by Total Assets
Key competitors of Journey Medical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Journey Medical Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Journey Medical Corp generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Journey Medical Corp is currently not profitable relative to its asset base.
Journey Medical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.38 | 7.04 |
| Quick Ratio | 1.12 | 1.03 | 6.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $16.67 Million | $ 12.83 Million | $ 353.88 Million |
Journey Medical Corp - Advanced Valuation Insights
This section examines the relationship between Journey Medical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.97 |
| Latest Market Cap to Assets Ratio | 1.58 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | $80.24 Million |
| Market Capitalization | $127.11 Million USD |
Valuation Analysis
Above Book Valuation: The market values Journey Medical Corp's assets above their book value (1.58 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Journey Medical Corp's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Journey Medical Corp (2014–2024)
The table below shows the annual total assets of Journey Medical Corp from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $80.24 Million | +4.41% |
| 2023-12-31 | $76.85 Million | -26.92% |
| 2022-12-31 | $105.16 Million | +8.10% |
| 2021-12-31 | $97.28 Million | +87.42% |
| 2020-12-31 | $51.91 Million | +53.30% |
| 2019-12-31 | $33.86 Million | -90.17% |
| 2018-12-31 | $344.32 Million | -38.60% |
| 2017-12-31 | $560.79 Million | +79.40% |
| 2016-12-31 | $312.60 Million | +40.85% |
| 2015-12-31 | $221.93 Million | +24.53% |
| 2014-12-31 | $178.22 Million | -- |